SAINT BELLA Inc. 聖貝拉有限公司 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） （股份代號：2508） 審核委員會的職權範圍 聖貝拉有限公司（「本公司」）審核委員會（「審核委員會」）應由本公司董事會（「董 事會」）設立。下文載列審核委員會的職權範圍（「職權範圍」）。倘職權範圍的英 文及繁體中文版本有任何歧義，則以英文版本為準。 1. 目的 1.1 審核委員會的目的為協助董事會建立正式及透明的安排，以考慮董事會 應如何應用財務報告、風險管理、審計及內部控制原則，並與本公司審計 師保持適當關係以及董事會不時決定的有關其他事項。 2. 成員 3.1 審核委員會秘書由本公司聯席秘書兼任。 3.2 審核委員會可不時委任任何其他具備適當資格及經驗的人士擔任審核委 員會秘書。 4.1 審核委員會每年至少召開兩次會議，或倘情況有需要，則更頻繁召開會議。 審核委員會的任何成員或秘書均可召集會議。必要時，本公司外部審計師 可召開會議。 4.2 審核委員會成員應每年至少兩次與本公司審計師會面，而本公司執行董 事不得出席（除非獲審核委員會邀請）。 4.3 任何會議應至少提前14天發出通知，除非審核委 ...

Core Viewpoint - The launch of the IPO by Saint Bella, a leading brand in the global home care sector, highlights the growing interest in high-end lifestyle services and the long-term value seen by investors like GIMM [1][2] Group 1: Market Trends and Opportunities - The continuous optimization of China's consumption structure and the evolution of supply and demand in the service industry position lifestyle services as a crucial sector for connecting "better living" with industrial upgrades [1] - The high-end maternal and infant care and family health care markets are entering a phase of accelerated development in intelligent care and comprehensive health management, with expectations of significant quality supply and professional services in the next three to five years [2] Group 2: Company Strategy and Investments - 58.com has been systematically expanding its presence in the local lifestyle service industry, focusing on various segments such as hairdressing, fitness, and health care, with investments in leading brands like Youjian and UU Running [2] - The company aims to enhance its platform ecosystem's collaborative capabilities and drive the digital transformation of traditional services from fragmentation and inefficiency to scale, standardization, and digitization [2] Group 3: Digital Transformation and AI Integration - The ongoing demographic changes and the acceleration of aging populations necessitate improvements in service efficiency and quality, with a projected talent gap exceeding ten million in fields like home services and elderly care by 2024 [3] - 58.com is enhancing its "platform + AI" capabilities to improve digital infrastructure and drive technological upgrades across ecosystem enterprises, focusing on areas like real estate transactions and intelligent home services [3][4] - The company has established a nationwide real estate data engine covering over 700 cities, with its AI matching system processing over ten million interactions daily to optimize transaction efficiency [4][5] Group 4: AI Capabilities and Ecosystem Development - 58.com is advancing AI from a platform tool to an industrial intelligence engine, planning to embed AI deeply into over 200 scenarios in the next three years, making it an essential infrastructure for businesses and workers [7] - The integration of AI capabilities with local lifestyle services is being pursued through investments in robotics, expanding the boundaries of the AI intelligent ecosystem [7][8] - The company is creating a smart lifestyle service ecosystem that enhances efficiency and user experience, with AI permeating every aspect of service scenarios, such as automated task assignments and online property transactions [8]

Summary of Key Points Core Viewpoint The article provides an overview of the recent activities in the Hong Kong stock market, highlighting the number of companies that have submitted applications for listing, those that have passed the hearing, and details about their financial performance and market positions. Group 1: New Applications - A total of 19 companies submitted applications to the Hong Kong Stock Exchange from June 16 to June 22 [3] - New Hope Group (600803.SH) is the largest private natural gas company in China, with a market share of approximately 6.1% in 2024 [3] - Wolong Technology (002130.SZ) is the second-largest high-speed copper cable manufacturer globally, holding a 24.9% market share [4] - Beijing Geekplus Technology Co., Ltd. is the largest provider of AMR solutions globally, maintaining its leading position for six consecutive years [5] - Banu International Holdings is the largest hot pot brand in China by revenue, with a market share of 3.1% [6] - Hope Sea Inc. is the largest comprehensive electronic product import supply chain solution provider in China, with an import GMV of approximately RMB 34.8 billion in 2024 [7] - Guangzhou Shiyuan Electronic Technology Co., Ltd. ranks first in the Chinese market for interactive smart panels with a 25.0% market share [8] - Anmai Biotechnology Co., Ltd. ranks second globally in T-cell connector therapy, with total transaction values exceeding USD 2.1 billion [9] - Beijing Haizhi Technology Group focuses on industrial-grade AI solutions, ranking fifth in the Chinese market [10] - Suzhou Jiyi Technology Co., Ltd. ranks second in digital retail operations in China [11] - Drip Irrigation International Investment Co., Ltd. is the first global exchange group based on revenue-sharing models [12] - Zhaowei Electromechanical (003021.SZ) provides integrated micro-drive systems, with revenues projected to grow [13] - Meige Intelligent (002881.SZ) ranks fourth globally in wireless communication modules, holding a 6.4% market share [14] - Yuxin Technology (300674.SZ) is a leading fintech solution provider in China, with significant market shares in various sectors [15] - Shanghai Zhuoyue Ruixin Digital Technology Co., Ltd. ranks second in the digital education market for higher education in China [16] - Zhaoyi Innovation (603986.SH) is the second-largest NOR Flash provider globally, with an 18.5% market share [17] - Changchun Changguang Chenxin Microelectronics Co., Ltd. specializes in high-performance CMOS image sensors [18] - Weichai Lovol Smart Agriculture Technology Co., Ltd. is a leading provider of smart agricultural solutions in China [19] - PPIO is an independent distributed cloud computing service provider [20] - Xiangkang Holdings is a major technical apparel manufacturer for high-end brands [22] Group 2: Companies Passing Hearings - Four companies passed the listing hearing this week, including Fuwai Group, which is a pan-Asian life insurance company with projected insurance revenue growth [24] - Fengcai Technology focuses on chip design for BLDC motor control, ranking sixth in the Chinese market [25] - Xunzhong Communication Technology Co., Ltd. is the third-largest cloud communication service provider in China [26] - Cloudbreak Pharma Inc. is a clinical-stage ophthalmic biotech company with two core products [27] Group 3: Recent IPOs - Haitan Flavor Industry (03288.HK) raised approximately HKD 10.1 billion in its IPO, with a slight decline in stock price post-listing [28] - Sanhua Intelligent (02050.HK) had a strong subscription rate for its IPO [29] - Baize Medical (02609.HK) and other companies also reported significant subscription rates for their IPOs [30][31][32][33]

Market Overview - A-shares experienced a slight decline this week, with the Shanghai Composite Index down 0.51% closing at 3360 points, and the Wind All A Index down 1.07% [1] - Hong Kong stocks mirrored A-shares, with the Hang Seng Index dropping 1.52% and the Hang Seng Tech Index down 2.03% [2] - U.S. stock indices showed mixed performance, with the Dow Jones and Nasdaq rising while the S&P 500 fell [3] Positive Developments - Novo Nordisk announced significant weight loss results from its STEP UP 3b clinical trial, showing a 21% average weight reduction for participants on a higher dose of Wegovy, with one-third achieving over 25% weight loss [3] - Lao Pu Gold opened its first overseas store in Singapore, marking a key step in its global expansion strategy [3] - Zhifei Biological received clinical trial approval for its adsorbed tetanus vaccine, allowing it to proceed with trials [4] - Tencent Cloud launched "AI Builder," enabling users to generate complete applications from simple descriptions, enhancing the app development experience [5] - Xin Xuan Group reported significant sales during the 618 shopping festival, with 12 brands exceeding 100 million in sales and total viewership reaching 550 million [6][7] - Heng Rui Pharmaceutical received approval for six drug clinical trials, including new oral and injectable therapies [8] - Li Auto's first pure electric SUV, the Li i8, is set to launch in late July [9] - Yingmu Technology plans to release a new strategic product in Q3 [10] - Desay SV announced a partnership with Chery Automobile to develop an integrated central computing platform for smart driving [11] Negative Developments - Anker Innovations announced a recall of certain batches of power banks due to quality issues with battery cells [12] - The Shanghai Stock Exchange is monitoring stocks with abnormal trading behaviors, including *ST Yanzhen [13] - Ningbo Huaxiang expects a loss of 273 million to 369 million yuan in the first half of 2025 due to the impact of its European business divestiture [14][15] - *ST Jinguang received a decision to terminate its stock listing, entering a delisting period starting June 30, 2025 [16] - SpaceX's Starship S36 experienced an explosion during a static fire test [17] - Microsoft plans to lay off thousands of employees, primarily in sales [17] - *ST Xinyuan's controlling shareholder is restricted from high consumption due to a contract dispute [17] - *ST Hengli received a decision to terminate its stock listing, with trading resuming on June 25, 2025 [18] - Honda is recalling nearly 259,000 vehicles in the U.S. due to brake pedal issues [19] - Ford is recalling 27,768 vehicles in the U.S. due to a child lock malfunction [19] - Wanda Group's 40 million shares have been frozen [19] - Black Sesame received a warning letter from the Guangxi Securities Regulatory Bureau for governance issues [20][21] - *ST Jiu You announced its stock will be delisted, entering a 15-day trading period before delisting [22] - San Yao Biotech terminated its exclusive agreement with Guoguang Biotech, affecting its flu vaccine distribution in mainland China [23] IPO and Market Activity - Haitian Flavoring's H-shares were priced at HKD 36.3, with additional shares issued [35] - The China Securities Regulatory Commission approved Guangdong Jian Ke's IPO registration for the Growth Enterprise Market [28] - Several companies, including PPIO and PPLabs Technology, submitted IPO applications to the Hong Kong Stock Exchange [26][29] - The Hong Kong Stock Exchange reported that approximately 190 companies are in line to go public [45]

Group 1: Company Overview - Saint Bella, established in 2017 and headquartered in Hangzhou, Zhejiang, is a leading brand in China's high-end maternal and infant care sector, offering postpartum care and related services [2] - The company is known as the "Hermès of the maternity center industry," with 28-day package prices ranging from 68,800 to 220,000 RMB, attracting high-profile clients [2] - As of June 3, 2025, Saint Bella's network covers 27 first- and second-tier cities in mainland China, as well as Hong Kong, Singapore, and the Greater Los Angeles area, with 96 maternity centers [2] Group 2: Financial Performance - Revenue for Saint Bella from 2022 to 2024 was 472 million, 560 million, and 799 million RMB, respectively, with a compound annual growth rate of 30% driven by new store openings [3] - The company reported net losses of 411.6 million, 238.9 million, and 543.3 million RMB for the same years, with adjusted net profits showing significant fluctuations [3][4] - The main revenue source is the maternity center business, which accounted for 85% of total revenue in 2024, while family care services and women's health products contributed 8.6% and 6.4%, respectively [4] Group 3: Business Model and Strategy - Saint Bella employs a light asset model, partnering with luxury hotels to avoid property construction, allowing for rapid store openings within three months [5] - The brand matrix includes ultra-high-end (Saint Bella), high-end (Ai Yu), and affordable luxury (Xiao Bella) to cater to different customer segments, although mid- to low-end brands contribute 70% of store count and revenue growth [5] - The company has a high customer retention rate, with 38% of orders coming from referrals and an 84% repurchase rate, primarily targeting high-net-worth clients [5] Group 4: Market Position and IPO Details - Saint Bella's market capitalization is 39 billion HKD, with an IPO planned to raise approximately 628 million HKD, representing 16.03% of total shares [6][8] - The company is expected to have a high subscription rate, with estimates suggesting a potential oversubscription of over 100 times, which may lead to a lower allocation rate for public investors [8] - Compared to peers, Saint Bella's valuation is considered high at 93 times adjusted net profit, indicating that its growth potential may already be priced in [6]

Core Viewpoint - Saint Bella, the largest postpartum care and recovery group in Asia and China, has launched its global IPO, with significant interest from long-term and healthcare funds, indicating strong market confidence in the company [1][4]. Group 1: IPO Details - The global offering consists of 95.42 million shares, with 9.542 million shares available for public sale in Hong Kong and 85.878 million shares for international placement [1]. - The offering price is set at HKD 6.58 per share, aiming to raise approximately HKD 628 million, resulting in a post-IPO valuation of HKD 3.918 billion [1][10]. - The IPO subscription period ends on June 23, 2023, with plans for listing on the Hong Kong Stock Exchange on June 26, 2025 [1]. Group 2: Key Investors - Seven cornerstone investors have been introduced, collectively subscribing for USD 41.5 million (approximately HKD 325.3 million), including notable firms like Huaxia Fund and GIMM [3][4]. - The presence of both domestic leading fund companies and local state-owned enterprises among the cornerstone investors reflects strong recognition of the company's market position and performance [4]. Group 3: Business Overview - Founded in 2017, Saint Bella operates 96 high-end postpartum care centers, including 62 self-operated and 34 managed centers, making it the largest in Asia and China [5][6]. - The company has expanded its network rapidly, adding 11, 7, and 34 centers in 2022, 2023, and 2024, respectively [6][7]. Group 4: Financial Performance - Revenue for Saint Bella has shown significant growth, with figures of CNY 472 million, CNY 560 million, and CNY 799 million for 2022, 2023, and 2024, respectively, reflecting a compound annual growth rate of 30.1% [8][9]. - The growth is driven by the expansion of postpartum care services and the introduction of new products, with approximately 84% of postpartum care clients also utilizing other services [8]. Group 5: Future Plans - The company plans to open 55 new postpartum care centers from 2025 to 2029, focusing on acquisitions and organic growth to enhance market presence [11]. - Investment in AI technology is a priority, with plans to integrate AIoT devices to improve service delivery and customer experience [12].

Core Viewpoint - Saint Bella, recognized as the "first global high-end home care stock," has initiated its IPO, aiming to raise approximately HKD 628 million through the issuance of 95.42 million shares at a price of HKD 6.58 per share, with significant backing from cornerstone investors [1][3]. Group 1: Company Overview - Saint Bella plans to issue a total of 95.42 million shares, with 9.54 million shares available in Hong Kong and 85.88 million shares internationally, targeting a fundraising goal of HKD 628 million [1]. - The company has attracted seven cornerstone investors, including GIMM, Huaxia Fund (Hong Kong), JKKB, SS Morgan, and others, collectively subscribing to 49.44 million shares, amounting to approximately USD 41.46 million [1][3]. Group 2: Financial Performance and Valuation - Saint Bella has undergone seven rounds of financing since its establishment in 2017, raising over RMB 300 million, with notable investors including Tencent and other prominent capital firms [3]. - The company's estimated PE ratio is 7.93, significantly lower than the industry average of 22, indicating a high valuation attractiveness [5]. - The projected compound annual growth rate (CAGR) for revenue from 2022 to 2024 is 30%, suggesting strong growth potential [5]. Group 3: Business Model and Competitive Advantage - Saint Bella's business model is built on three pillars: high-end services, standardization, and digitalization, which together create a robust competitive moat [6][8]. - The company collaborates with high-end hotels to provide luxurious care environments and employs a large number of qualified nursing professionals to ensure high service standards [6][8]. - A comprehensive service model is established, covering postpartum care, family childcare, and health product supply, enhancing customer lifetime value [8]. Group 4: Market Opportunity and Industry Dynamics - The high-end home care sector is currently experiencing a "golden window period," driven by policy support and increasing demand, with Saint Bella positioned to capture significant market share [9][12]. - The penetration rate of postpartum care in China is expected to rise from 7.5% in 2019 to 17.0% by 2024, indicating substantial growth potential in the market [9]. - The company plans to allocate approximately 29% of the IPO proceeds to expand its postpartum care network and 37% to launch new services and products [13].

Group 1 - Haitai Weiye's dark market closed up 3.86% on June 18, with a final price of HKD 37.7 and a total market capitalization of HKD 219.56 billion, indicating strong market recognition [1] - The listing of Haitai Weiye on the Hong Kong Stock Exchange is expected to provide significant capital support and enhance its international visibility and brand influence [1] Group 2 - Shiyuan Technology submitted its listing application to the Hong Kong Stock Exchange on June 17, holding a leading position in the interactive smart panel and LCD main control board sectors [2] - The company's projected revenues for 2022 to 2024 are HKD 20.99 billion, HKD 20 billion, and HKD 22.4 billion, with net profits of HKD 2.1 billion, HKD 1.4 billion, and HKD 1 billion respectively [2] - The listing is a significant step for Shiyuan Technology towards the international capital market, which will enhance its brand influence [2] Group 3 - Xie Ruilin expects a loss of no more than HKD 200 million for the fiscal year ending March 31, 2025, a significant reduction of over 46% compared to the previous year's loss of HKD 374 million [3] - The improvement in performance is attributed to the successful implementation of business transformation strategies and increased profit contributions from its franchise operations in mainland China [3] - This positive trend indicates the company's potential for future financial performance and market competitiveness [3] Group 4 - Zhou Li Fu, Sheng Bei La, and Ying Tong Holdings are simultaneously conducting an IPO in Hong Kong, with subscription ending on June 23 [4] - The offering prices are set at HKD 24, HKD 2.8-3.28, and HKD 6.58 respectively, with cornerstone investors participating and all companies having an over-allotment option [4] - Zhou Li Fu is expanding rapidly through a franchise model, while Ying Tong Holdings boasts a strong brand portfolio and sales network; Sheng Bei La focuses on high-end postpartum care with significant revenue growth but increasing losses [4]

Core Viewpoint - The global family care leader, Saint Bella, has officially launched its IPO process, aiming to raise capital in a booming Hong Kong market, with a share price set at HKD 6.58 and a total offering of 95.42 million shares [1][2]. Group 1: Investment Highlights - Saint Bella's IPO has attracted a prestigious lineup of cornerstone investors, including the Hangzhou government-backed Xiaoshan District Industrial Fund, marking a significant regional benchmark [2][6]. - The strategic investment from the high-end private medical group, Harmony Family, is expected to create synergies between its medical resources and Saint Bella's care system, potentially forming a "high-end care + specialized medical" ecosystem [2]. - The participation of major public fund, Huaxia Fund, further underscores the recognition of the company's long-term value by mainstream capital [3]. Group 2: Financial Performance - Saint Bella's revenue has shown robust growth, increasing from CNY 472 million in 2022 to CNY 799 million in 2024, representing a compound annual growth rate (CAGR) of 30.15%, significantly outpacing the industry average [8]. - The adjusted net profit has turned from a loss in 2022 to a profit of CNY 20.77 million in 2023, and is projected to reach CNY 42.26 million in 2024, with a year-on-year growth rate of 103.43% [9]. Group 3: Market Position and Strategy - As the first global family care company to go public, Saint Bella is positioned as a benchmark in the industry, redefining the market landscape [7]. - The company has innovatively developed a comprehensive service ecosystem covering the entire family care cycle, creating strong competitive barriers and first-mover advantages [8]. - The diversified business model, extending from core maternal and infant care to home care and postpartum rehabilitation, is expected to drive significant revenue growth through synergistic effects [8]. Group 4: Capital Market Dynamics - The dual backing of top-tier investment banks, CITIC Securities and UBS, provides strong credibility to Saint Bella's IPO process, with their previous IPOs averaging a first-day increase of 33.3% [4]. - The combination of innovative business models, validated financial data, and strategic resource aggregation positions Saint Bella to redefine the value standards in the global family care industry [11].

Group 1 - The company, Sheng Bella, plans to conduct an IPO from June 18 to June 23, 2025, offering 95.42 million shares at a price of HKD 6.58 per share, with trading expected to commence on June 26, 2025 [1] - Sheng Bella is recognized as the largest postpartum care and recovery group in Asia and China, with a market share of approximately 1.2% based on revenue from maternity centers in 2024 [1] - The company aims to become Asia's leading integrated family care brand group by expanding its service network beyond existing markets in mainland China, Hong Kong, Singapore, and the United States [1] Group 2 - The company has entered into cornerstone investment agreements, with investors agreeing to subscribe for shares totaling up to USD 41.5 million, subject to certain conditions [2] - The estimated net proceeds from the global offering are approximately HKD 541 million, with 29% allocated for expanding the postpartum care network and 37% for launching new services and products [2] - Additional allocations include 6% for training professional family care experts, 18% for research and development activities, and 9% for working capital and other general corporate purposes [2]